Immunoglobulin Market Trends, Share, Size, Growth, Scope and Forecast 2021-2026
According to the latest report by IMARC Group, The global immunoglobulin market to grow at a CAGR of around 7% during 2021-2026.
SHERIDAN, WYOMING, UNITED STATES, April 12, 2022 /EINPresswire.com/ -- According to the latest report by IMARC Group “Immunoglobulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The global immunoglobulin market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026.
Immunoglobulins, also known as antibodies, are glycoprotein molecules formed by plasma cells or white blood cells (WBCs). They help identify and bind foreign antigens, such as viruses or bacteria and prevent the spread of infections to other parts of the body. As a result, they are used in the treatment of various neurological and immunological diseases worldwide.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request for a free sample copy of this report: https://www.imarcgroup.com/immunoglobulin-market/requestsample
Market Trends:
The increasing consumption of ready-to-eat (RTE) food products is leading to numerous medical conditions around the world. This, in confluence with the proven efficiency of immunoglobulins as an effective treatment for immune disorders, is positively influencing the market. Besides this, the growing geriatric population, which is more susceptible to chronic medical ailments like myeloma, is acting as another growth-inducing factor. Furthermore, technological advancements in purification techniques are creating a positive outlook for the market. Moreover, numerous research and development (R&D) activities by medical researchers to develop advanced and effective products are expected to drive the market.
Breakup by Product:
IgG
IgA
IgM
IgE
IgD
Breakup by Application:
Hypogammaglobulinemia
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immunodeficiency Disease
Myasthenia Gravis
Others
Breakup by Mode of Delivery:
Intravenous Mode of Delivery
Subcutaneous Mode of Delivery
Market Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Competitive Landscape with Key Player:
ADMA Biologics Inc.
Baxter international Inc.
Biotest AG
CSL Limited
Grifols S.A
Kedrion S.p.A
LFB SA
Octapharma AG
Sanquin Plasma Products B.V.
Takeda Pharmaceutical Company Limited.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://bit.ly/2X3PzmJ
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Related Reports
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here
